 |
Recombinant adeno-associated virus serotype 9 vector expressing codon-optimized miniaturized version of DMD gene |
|---|---|
| Trade Name | |
| Orphan Indication | Duchenne muscular dystrophy |
| USA Market Approval | USA |
| USA Designation Date | 2017-05-22 00:00:00 |
| Sponsor | Bamboo Therapeutics, w wholly owned subsidiary of Pfizer;Worldwide Safety & Regulatory, Pfizer Inc.;Groton, Connecticut, 06340 |
